Increasing Community Access to Testing and Treatment (ICATT) Pharmacy Services
ID: RFI_HCAD1_2025_00311Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

All Other Miscellaneous Ambulatory Health Care Services (621999)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/2ed66e9712844e0eacda8ef25ca16e82/view
Timeline
    Description

    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking partnerships with private contractors for the Increasing Community Access to Testing, Treatment, and Prevention (ICATT) Pharmacy Services program, which will run from June 1, 2025, to May 31, 2030. The procurement aims to provide comprehensive healthcare services, including nationwide testing, medical assessments, therapeutics, vaccinations, and emergency response capabilities, particularly targeting under-resourced communities. This initiative builds on the successful efforts during the COVID-19 pandemic and emphasizes the importance of public-private partnerships in enhancing public health infrastructure and accessibility. Interested contractors should submit their detailed responses to the Request for Information by October 22, 2024, with inquiries due by November 4, 2024; for further information, contact Dawn Redman at dredman@cdc.gov or Jorge Morales at xvx7@cdc.gov.

    Point(s) of Contact
    Dawn Redman
    (404) 498-3069
    dredman@cdc.gov
    Jorge Morales
    (404) 498-6068
    xvx7@cdc.gov
    Files
    Title
    Posted
    RFI SOW - ICATT Pharmacy Services Final.pdf
    The "Request for Information" outlines the government's initiative, called the Increasing Community Access to Testing, Treatment, and Prevention (ICATT) program, which seeks partnerships with private contractors to deliver essential healthcare services from June 1, 2025, through May 31, 2030. This program builds on prior efforts during the COVID-19 pandemic, aiming to enhance public health services by integrating testing, medical assessment, therapeutics, vaccination, and sample collection across underserved communities. The scope includes core services such as a variety of diagnostic testing options, medical assessments for prescription eligibility, administration of therapeutics and vaccines, and comprehensive surge services for emergencies. Contractors will be responsible for program management and fulfilling reporting and logistical needs, including data acquisition and outreach education. The document seeks feedback on contractors' readiness, management capabilities, and potential challenges to effectively execute the outlined tasks, reinforcing the significance of cooperative public-private efforts in ensuring healthcare accessibility and safety amidst ongoing health risks. This RFI reflects broader governmental efforts to maintain robust public health systems through innovative partnerships and resource allocation.
    Lifecycle
    Title
    Type
    Increasing Community Access to Testing and Treatment (ICATT) Pharmacy Services
    Currently viewing
    Sources Sought
    Similar Opportunities
    Diagnostic Test Development and Production for Emergency Response
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for the development and production of diagnostic tests aimed at enhancing emergency response capabilities for public health threats. The procurement involves multiple tasks, including the rapid development and validation of Nucleic Acid Amplification Tests for selected pathogens, regulatory submissions for Emergency Use Authorization (EUA), and the manufacturing of tests to meet outbreak demands. This initiative is critical for bolstering the national laboratory system's readiness and efficiency in addressing public health emergencies. Interested vendors must submit their proposals by December 13, 2024, with a maximum contract value of $148 million and a minimum order of $10,000. For further inquiries, vendors can contact Shayna Connery at xvj9@cdc.gov or Austin Pagliaccetti at zsm6@cdc.gov.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Decentralized Clinical Operations for Healthcare and Research (D-COHRe) Partnership Solicitation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals for the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program. This initiative aims to establish partnerships with organizations that provide decentralized healthcare services, such as retail pharmacies and telemedicine, to enhance clinical trial capabilities and support medical countermeasure development during public health emergencies. The program is critical for building a sustainable decentralized clinical research infrastructure, enabling efficient recruitment and participation in clinical studies within community settings. Proposals are due by December 9, 2024, at 12:00 PM EST, with an anticipated funding amount of up to $100 million distributed over a five-year performance period. Interested parties can direct inquiries to LaunchOfficeContracting@hhs.gov.
    Phase I - Serological Assays for the detection and characterization of influenza viruses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract focused on the development and execution of serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition assays on human sera for vaccine effectiveness studies and creating a new serology platform that matches the capabilities of existing assays, with an expected testing volume of approximately 6,000 samples annually. This initiative is crucial for enhancing public health responses to influenza through improved detection methodologies and is set within a framework that emphasizes small business participation and adherence to federal acquisition regulations. Interested parties can contact Jennifer Gartzke at jgartzke@cdc.gov or by phone at 404-498-0020 for further details, with the contract performance period commencing on April 28, 2025, and extending through optional periods thereafter.
    RFI for World Trade Center Health Program (WTCHP) Mental Health Evaluation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking qualified vendors to respond to a Request for Information (RFI) aimed at developing a specialized mental health provider network for the World Trade Center Health Program (WTCHP). The primary objective is to address the unique mental health needs of WTCHP members, particularly those affected by 9/11-related conditions, by ensuring timely access to outpatient services and integrating these services with existing care teams while overcoming challenges such as provider shortages and billing complexities. This initiative is crucial for enhancing the quality of care and service delivery for individuals impacted by the events of September 11, 2001. Interested parties are encouraged to submit their responses detailing their experience and proposed solutions by contacting Eugenia J. Corder at xvn9@cdc.gov or by phone at 404-498-4855. This RFI is for information and planning purposes only and does not constitute a solicitation for proposals.
    I-Corps Program at the National Cancer Institute.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Cancer Institute (NCI), is seeking a contractor to support the I-Corps Program aimed at commercializing biomedical innovations. The contractor will facilitate a structured training program for up to eight teams, which includes a three-day kickoff workshop, six weeks of virtual training, and a two-day closing workshop, with the inaugural cohort tentatively scheduled for August/September 2025. This initiative underscores the government's commitment to enhancing public health by fostering innovation and supporting small businesses in the healthcare sector. Interested parties should submit their capability statements to Elizabeth Vitucci at elizabeth.tucker@nih.gov by 3:00 PM EST on November 20, 2024, and must be registered with SAM.GOV to be eligible for contract award.
    RFI - World Trade Center (WTC) Health Program's Medical Coding System Transition
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking insights from qualified organizations regarding the transition of the World Trade Center (WTC) Health Program's medical coding system from ICD-9 to ICD-10 and beyond. The primary objective of this Request for Information (RFI) is to identify effective methods for automating updates to member certification files, ensuring alignment with valid ICD codes to maintain the integrity of the certification process for 9/11 Responders and Survivors. This initiative is crucial for ensuring continued access to necessary healthcare services for individuals affected by the events of September 11, 2001, as established under the James Zadroga 9/11 Health and Compensation Act of 2010. Interested parties are invited to submit a white paper by November 26, 2024, detailing their experience and capabilities related to coding transitions, with inquiries directed to Laurie Presley at xnp0@cdc.gov.
    Waste Removal and Recycling Services - NIOSH Pittsburgh
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified contractors to provide waste removal and recycling services at the NIOSH Pittsburgh facility. The procurement involves a firm-fixed-price contract for municipal waste and recycling disposal services, with a performance period starting January 1, 2025, and extending through December 31, 2029, including one base year and four optional years. This contract is crucial for maintaining environmental compliance and operational efficiency at the CDC's research center, ensuring proper waste management practices are upheld. Interested parties must submit their proposals by 2:00 PM EST on December 2, 2024, and direct any inquiries to Joseph Butkus at jbutkus@cdc.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Chemistry, Manufacturing, and Controls (CMC) services to support the development of drug products. The primary objective of this procurement is to ensure the provision of high-quality formulated drug products necessary for preclinical and clinical studies, adhering to current Good Manufacturing Practice (cGMP) regulations. This contract is crucial for advancing human therapeutics by facilitating the movement of drug candidates through the preclinical development process until the submission of Investigational New Drug (IND) applications. The Request for Proposals (RFP) is expected to be released on or about December 2, 2024, with contract awards anticipated in the third quarter of FY2025. Interested parties can contact Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    2026 NIAID DMID Omnibus Broad Agency Announcement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the 2026 NIAID DMID Omnibus Broad Agency Announcement (BAA) aimed at advancing medical countermeasures against infectious diseases. This opportunity encompasses two primary research areas: the development of therapeutics, vaccines, and diagnostics for antimicrobial-resistant pathogens, and the creation of direct acting antivirals targeting viruses with pandemic potential. The initiative is critical for enhancing public health responses to emerging infectious threats and includes funding estimates of up to $8.5 million for Research Area 001 and $20 million for Research Area 002, with proposals due to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) platform, starting around November 22, 2024. For further inquiries, interested parties may contact Swee L. Teo at teosl@niaid.nih.gov or Brian Madgey at brian.madgey@nih.gov.